ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,971Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 103

$488K Total Retail Price of All Prescriptions

Rank: 38 out of 103

420 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 420 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,513 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 780 735 1 2
LEVOTHYROXINE SODIUM 706 661 2 1
OMEPRAZOLE 662 592 3 3
FUROSEMIDE 613 571 4 4
LISINOPRIL 514 462 5 5
WARFARIN SODIUM 458 431 6 7
LOSARTAN POTASSIUM 424 405 7 12
AMLODIPINE BESYLATE 409 391 8 6
METOPROLOL SUCCINATE 407 368 9 8
ATENOLOL 343 331 10 14
METFORMIN HCL 272 256 11 13
ATORVASTATIN CALCIUM 214 209 12 18
METOPROLOL TARTRATE 212 192 13 9
SERTRALINE HCL 210 203 14 21
ALENDRONATE SODIUM 206 179 15 19
POTASSIUM CHLORIDE 192 175 16 10
CITALOPRAM HBR 189 139 17 15
HYDROCODONE-ACETAMINOPHEN 181 155 S3 18 11
ALLOPURINOL 162 130 19 26
CRESTOR 154 126 20 27
TAMSULOSIN HCL 142 125 21 23
CARVEDILOL 140 133 22 20
PRAVASTATIN SODIUM 135 117 23 33
HYDROCHLOROTHIAZIDE 134 133 24 16
TRIAMTERENE-HCTZ 129 112 25 38
RAMIPRIL 127 120 26 126
DIOVAN 126 117 27 40
PREDNISONE 126 117 27 24
GABAPENTIN 116 107 29 22
DIGOXIN 109 91 30 25
FLUTICASONE PROPIONATE 108 86 31 35
DONEPEZIL HCL 108 108 31 28
MIRTAZAPINE 105 101 33 36
CLOPIDOGREL 98 79 34 32
KLOR-CON M20 97 96 35 56
MELOXICAM 93 68 36 49
ZOLPIDEM TARTRATE 91 90 37 29
TRAZODONE HCL 89 69 38 52
FINASTERIDE 88 76 39 69
KLOR-CON 10 86 81 40 45
POLYETHYLENE GLYCOL 3350 85 75 41 31
LANTUS 81 66 42 39
ADVAIR DISKUS 79 79 43 42
CLONIDINE HCL 71 71 44 82
LOSARTAN-HYDROCHLOROTHIAZIDE 71 71 44 47
QUINAPRIL HCL 71 61 44 131
NEXIUM 65 65 47 43
DOXAZOSIN MESYLATE 65 65 47 90
AMITRIPTYLINE HCL 62 50 R 49 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 61 50 48
PROPRANOLOL HCL 60 48 51 87
RISPERIDONE 60 53 51 88
GLIPIZIDE ER 59 54 53 113
NAMENDA 58 58 54 41
PLAVIX 57 47 55 46
NOVOLOG 56 37 56 94
SPIRONOLACTONE 53 53 57 30
DETROL LA 51 51 58 146
FENTANYL 50 33 S2 59 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.